Polysaccharides as Nanomaterials for Therapeutics - Harnessing Biomaterials in Nanomedicine: Preparation, Toxicity, and Applications - page 152

26. Hamman JH (2010) Chitosan based polyelectrolyte complexes as
potential carrier materials in drug delivery systems. Mar Drugs 8:
1305-1322.
27. Jing W, DeAngelis PL (2004) Synchronized chemoenzymatic synthesis
of monodisperse hyaluronan polymers. J Biol Chem 279: 42345-
42349.
28. DeAngelis PL, Oatman LC, Gay DF (2003) Rapid chemoenzymatic
synthesis of monodisperse hyaluronan oligosaccharides with
immobilized enzyme reactors. J Biol Chem 278: 35199-35203.
29. Pouyani T, Prestwich GD (1994) Functionalized derivatives of
hyaluronic acid oligosaccharides: drug carriers and novel biomaterials.
Bioconjug Chem 5: 339-347.
30. Prestwich GD, Marecak DM, Marecek JF, Vercruysse KP, Ziebell MR
(1998) Controlled chemical modification of hyaluronic acid: synthesis,
applications, and biodegradation of hydrazide derivatives. J Control
Release 53: 93-103.
31. Mohapatra S, Yang X, Wright JA, Turley EA, Greenberg AH (1996) Soluble
hyaluronan receptor RHAMM induces mitotic arrest by suppressing
Cdc2 and cyclin B1 expression. J Exp Med 183: 1663-1668.
32. Day AJ, Prestwich GD (2002) Hyaluronan-binding proteins: tying up
the giant. J Biol Chem 277: 4585-4588.
33. Shigeishi H, Fujimoto S, Hiraoka M, Ono S, Taki M, et al. (2009)
Overexpression of the receptor for hyaluronan-mediated motility,
correlates with expression of microtubule-associated protein in
human oral squamous cell carcinomas. Int J Oncol 34: 1565-1571.
34. Krause DS, Spitzer TR, Stowell CP (2010) The concentration of CD44
is increased in hematopoietic stem cell grafts of patients with acute
myeloid leukemia, plasma cell myeloma, and non-Hodgkin lymphoma.
Arch Pathol Lab Med 134: 1033-1038.
35. Borgstrom S, Gelin LE, Zederfeldt B (1959) The formation of vein
thrombi following tissue injury: an experimental study in rabbits. Acta
Chir Scand Suppl 247: 1-36.
36. Nimesh S, Kumar R, Chandra R (2006) Novel polyallylamine-dextran
sulfate-DNA nanoplexes: highly efficient non-viral vector for gene
delivery. Int J Pharm 320: 143-149.
37. Zimmermann K, Preinl G, Ludwig H, Greulich KO (1983) Inhibition
of hyaluronidase by dextran sulfate and its possible application in
anticancer treatment. J Cancer Res Clin Oncol 105: 189-190.
38. Wetzel GD, Kettman JR (1981) Activation of murine B cells. II. Dextran
sulfate removes the requirement for cellular interaction during
lipopolysaccharide-induced mitogenesis. Cell Immunol 61: 176-189.